Published in J Bacteriol on August 01, 2000
The evolution of gene collectives: How natural selection drives chemical innovation. Proc Natl Acad Sci U S A (2008) 2.71
Functional microdomains in bacterial membranes. Genes Dev (2010) 2.50
The genome of deep-sea vent chemolithoautotroph Thiomicrospira crunogena XCL-2. PLoS Biol (2006) 2.43
Comparative genomics reveal extensive transposon-mediated genomic plasticity and diversity among potential effector proteins within the genus Coxiella. Infect Immun (2008) 2.38
Comprehensive identification of essential Staphylococcus aureus genes using Transposon-Mediated Differential Hybridisation (TMDH). BMC Genomics (2009) 2.17
An unusual isopentenyl diphosphate isomerase found in the mevalonate pathway gene cluster from Streptomyces sp. strain CL190. Proc Natl Acad Sci U S A (2001) 2.00
Origin and molecular evolution of the determinant of methicillin resistance in staphylococci. Antimicrob Agents Chemother (2010) 1.74
Enzymes of the mevalonate pathway of isoprenoid biosynthesis. Arch Biochem Biophys (2010) 1.60
Discovery of a small molecule that blocks wall teichoic acid biosynthesis in Staphylococcus aureus. ACS Chem Biol (2009) 1.37
Essentiality, expression, and characterization of the class II 3-hydroxy-3-methylglutaryl coenzyme A reductase of Staphylococcus aureus. J Bacteriol (2000) 1.34
Antibacterial activity of a competence-stimulating peptide in experimental sepsis caused by Streptococcus pneumoniae. Antimicrob Agents Chemother (2004) 1.23
GcpE is involved in the 2-C-methyl-D-erythritol 4-phosphate pathway of isoprenoid biosynthesis in Escherichia coli. J Bacteriol (2001) 1.21
Lovastatin has significant activity against zygomycetes and interacts synergistically with voriconazole. Antimicrob Agents Chemother (2006) 1.13
Enterococcus faecalis acetoacetyl-coenzyme A thiolase/3-hydroxy-3-methylglutaryl-coenzyme A reductase, a dual-function protein of isopentenyl diphosphate biosynthesis. J Bacteriol (2002) 1.09
Roles of rel(Spn) in stringent response, global regulation and virulence of serotype 2 Streptococcus pneumoniae D39. Mol Microbiol (2009) 1.09
Human mevalonate diphosphate decarboxylase: characterization, investigation of the mevalonate diphosphate binding site, and crystal structure. Arch Biochem Biophys (2008) 1.07
Staphylococcus aureus mevalonate kinase: isolation and characterization of an enzyme of the isoprenoid biosynthetic pathway. J Bacteriol (2004) 1.06
Class II 3-hydroxy-3-methylglutaryl coenzyme A reductases. J Bacteriol (2004) 1.05
Synthesis of CDP-activated ribitol for teichoic acid precursors in Streptococcus pneumoniae. J Bacteriol (2008) 1.05
Uncovering metabolic pathways relevant to phenotypic traits of microbial genomes. Genome Biol (2009) 1.04
Crystal structures of Staphylococcus epidermidis mevalonate diphosphate decarboxylase bound to inhibitory analogs reveal new insight into substrate binding and catalysis. J Biol Chem (2011) 1.03
Enterococcus faecalis 3-hydroxy-3-methylglutaryl coenzyme A synthase, an enzyme of isopentenyl diphosphate biosynthesis. J Bacteriol (2002) 1.02
Superessential reactions in metabolic networks. Proc Natl Acad Sci U S A (2012) 1.02
Studies on the antibacterial effects of statins--in vitro and in vivo. PLoS One (2011) 1.00
Structure of the ternary complex of phosphomevalonate kinase: the enzyme and its family. Biochemistry (2009) 1.00
3-hydroxy-3-methylglutaryl-CoA synthase intermediate complex observed in "real-time". Proc Natl Acad Sci U S A (2004) 0.99
Effect of levels of acetate on the mevalonate pathway of Borrelia burgdorferi. PLoS One (2012) 0.98
The mevalonate pathway of Staphylococcus aureus. J Bacteriol (2008) 0.98
Functional analysis of genes involved in the biosynthesis of isoprene in Bacillus subtilis. Appl Microbiol Biotechnol (2007) 0.98
Characterization of a feedback-resistant mevalonate kinase from the archaeon Methanosarcina mazei. Appl Environ Microbiol (2011) 0.98
Cyclopiazonic acid biosynthesis of Aspergillus flavus and Aspergillus oryzae. Toxins (Basel) (2009) 0.97
Metabolic engineering of Escherichia coli for high-specificity production of isoprenol and prenol as next generation of biofuels. Biotechnol Biofuels (2013) 0.96
New aspects on lanosterol 14alpha-demethylase and cytochrome P450 evolution: lanosterol/cycloartenol diversification and lateral transfer. J Mol Evol (2004) 0.96
Diversity of carotenoid synthesis gene clusters from environmental Enterobacteriaceae strains. Appl Environ Microbiol (2005) 0.95
Novel antibiofilm chemotherapy targets exopolysaccharide synthesis and stress tolerance in Streptococcus mutans to modulate virulence expression in vivo. Antimicrob Agents Chemother (2012) 0.94
Enterococcus faecalis phosphomevalonate kinase. Protein Sci (2005) 0.91
Probing ligand-binding pockets of the mevalonate pathway enzymes from Streptococcus pneumoniae. J Biol Chem (2010) 0.90
Functional evaluation of conserved basic residues in human phosphomevalonate kinase. Biochemistry (2007) 0.90
Inhibition of the class II HMG-CoA reductase of Pseudomonas mevalonii. Protein Sci (2004) 0.90
Structural basis for nucleotide binding and reaction catalysis in mevalonate diphosphate decarboxylase. Biochemistry (2012) 0.90
Exploring the existence of lipid rafts in bacteria. Microbiol Mol Biol Rev (2015) 0.88
Crystal structure of the Streptococcus pneumoniae mevalonate kinase in complex with diphosphomevalonate. Protein Sci (2007) 0.88
A novel in silico approach to identify potential therapeutic targets in human bacterial pathogens. Hugo J (2011) 0.87
Divergent Isoprenoid Biosynthesis Pathways in Staphylococcus Species Constitute a Drug Target for Treating Infections in Companion Animals. mSphere (2016) 0.86
Enterococcus faecalis mevalonate kinase. Protein Sci (2004) 0.85
Pathway length and evolutionary constraint in amino acid biosynthesis. J Mol Evol (2004) 0.85
In vitro and in vivo validation of ligA and tarI as essential targets in Staphylococcus aureus. Antimicrob Agents Chemother (2008) 0.84
Mevalonate analogues as substrates of enzymes in the isoprenoid biosynthetic pathway of Streptococcus pneumoniae. Bioorg Med Chem (2009) 0.84
Overexpressing 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGR) in the lactococcal mevalonate pathway for heterologous plant sesquiterpene production. PLoS One (2012) 0.84
Molecular cloning of a new cDNA and expression of 3-hydroxy-3-methylglutaryl-CoA synthase gene from Hevea brasiliensis. Planta (2005) 0.83
A carotenoid synthesis gene cluster from Algoriphagus sp. KK10202C with a novel fusion-type lycopene beta-cyclase gene. Mol Genet Genomics (2006) 0.83
Structural analysis of mevalonate-3-kinase provides insight into the mechanisms of isoprenoid pathway decarboxylases. Protein Sci (2014) 0.81
Detection of eubacterial 3-hydroxy-3-methylglutaryl coenzyme a reductases from natural populations of actinomycetes. Microb Ecol (2003) 0.80
Mevalonate kinase deficiency: current perspectives. Appl Clin Genet (2016) 0.80
From microbial gene essentiality to novel antimicrobial drug targets. BMC Genomics (2014) 0.79
Identification of novel small molecule inhibitors of 4-diphosphocytidyl-2-C-methyl-D-erythritol (CDP-ME) kinase of Gram-negative bacteria. Bioorg Med Chem (2011) 0.79
Lineage structure of Streptococcus pneumoniae may be driven by immune selection on the groEL heat-shock protein. Sci Rep (2017) 0.78
Synthesis of mevalonate- and fluorinated mevalonate prodrugs and their in vitro human plasma stability. Eur J Med Chem (2014) 0.77
Genomic Landscape of Intrahost Variation in Group A Streptococcus: Repeated and Abundant Mutational Inactivation of the fabT Gene Encoding a Regulator of Fatty Acid Synthesis. Infect Immun (2016) 0.77
Enhanced C30 carotenoid production in Bacillus subtilis by systematic overexpression of MEP pathway genes. Appl Microbiol Biotechnol (2015) 0.76
Formal Synthesis of 4-diphosphocytidyl-2-C-methyl D-erythritol From D-(+)-Arabitol. Tetrahedron (2012) 0.76
A novel role for coenzyme A during hydride transfer in 3-hydroxy-3-methylglutaryl-coenzyme A reductase. Biochemistry (2013) 0.76
Uncovering major genomic features of essential genes in Bacteria and a methanogenic Archaea. FEBS J (2015) 0.76
Statin therapy in critical illness: an international survey of intensive care physicians' opinions, attitudes and practice. BMC Clin Pharmacol (2012) 0.75
Nonselective mevalonate kinase inhibitor as a novel class of antibacterial agents. Cholesterol (2015) 0.75
The increasingly complex mechanism of HMG-CoA reductase. Acc Chem Res (2013) 0.75
The mevalonate auxotrophic mutant of Staphylococcus aureus can adapt to mevalonate depletion. Antimicrob Agents Chemother (2013) 0.75
Backbone 1H, 13C, 15N NMR assignments of the unliganded and substrate ternary complex forms of mevalonate diphosphate decarboxylase from Streptococcus pneumoniae. Biomol NMR Assign (2010) 0.75
Kinetics of phosphomevalonate kinase from Saccharomyces cerevisiae. PLoS One (2014) 0.75
The Putative mevalonate diphosphate decarboxylase from Picrophilus torridus is in reality a mevalonate-3-kinase with high potential for bioproduction of isobutene. Appl Environ Microbiol (2015) 0.75
Thiamin Diphosphate Activation in 1-Deoxy-d-xylulose 5-Phosphate Synthase: Insights into the Mechanism and Underlying Intermolecular Interactions. J Phys Chem B (2016) 0.75
Bacteriostatic Effect of Simvastatin on Selected Oral Streptococci in Vitro. Contemp Clin Dent (2017) 0.75
Active site binding modes of inhibitors of Staphylococcus aureus mevalonate diphosphate decarboxylase from docking and molecular dynamics simulations. J Mol Model (2015) 0.75
Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res (1997) 665.31
CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res (1994) 392.47
Amino acid substitution matrices from protein blocks. Proc Natl Acad Sci U S A (1992) 61.33
STUDIES ON THE CHEMICAL NATURE OF THE SUBSTANCE INDUCING TRANSFORMATION OF PNEUMOCOCCAL TYPES : INDUCTION OF TRANSFORMATION BY A DESOXYRIBONUCLEIC ACID FRACTION ISOLATED FROM PNEUMOCOCCUS TYPE III. J Exp Med (1944) 24.08
Regulation of the mevalonate pathway. Nature (1990) 18.25
Genome sequence of an obligate intracellular pathogen of humans: Chlamydia trachomatis. Science (1998) 13.64
The complete genome of the hyperthermophilic bacterium Aquifex aeolicus. Nature (1998) 7.77
An unmodified heptadecapeptide pheromone induces competence for genetic transformation in Streptococcus pneumoniae. Proc Natl Acad Sci U S A (1995) 7.29
Integration efficiency and genetic recombination in pneumococcal transformation. Genetics (1966) 6.67
Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent. Proc Natl Acad Sci U S A (1980) 6.31
Selfish operons: horizontal transfer may drive the evolution of gene clusters. Genetics (1996) 5.88
Isoprenoid biosynthesis in bacteria: a novel pathway for the early steps leading to isopentenyl diphosphate. Biochem J (1993) 5.32
Selfish operons and speciation by gene transfer. Trends Microbiol (1997) 4.30
Archaea and the prokaryote-to-eukaryote transition. Microbiol Mol Biol Rev (1997) 3.94
Biosynthesis of isoprenoids in higher plant chloroplasts proceeds via a mevalonate-independent pathway. FEBS Lett (1997) 3.66
The structure of bactoprenol, a lipid formed by lactobacilli from mevalonic acid. Biochem J (1966) 3.33
Cytidine 5'-triphosphate-dependent biosynthesis of isoprenoids: YgbP protein of Escherichia coli catalyzes the formation of 4-diphosphocytidyl-2-C-methylerythritol. Proc Natl Acad Sci U S A (1999) 2.47
Constitutive expression of erythromycin resistance mediated by the ermAM determinant of plasmid pAM beta 1 results from deletion of 5' leader peptide sequences. Plasmid (1987) 2.36
Carotenoid formation by Staphylococcus aureus. J Bacteriol (1970) 1.57
Gene descent, duplication, and horizontal transfer in the evolution of glutamyl- and glutaminyl-tRNA synthetases. J Mol Evol (1999) 1.52
Sequence comparisons reveal two classes of 3-hydroxy-3-methylglutaryl coenzyme A reductase. Mol Genet Metab (1999) 1.48
Microbial carotenoids. Adv Biochem Eng Biotechnol (1996) 1.47
Crystal structure of Pseudomonas mevalonii HMG-CoA reductase at 3.0 angstrom resolution. Science (1995) 1.44
Cloning and characterization of ERG8, an essential gene of Saccharomyces cerevisiae that encodes phosphomevalonate kinase. Mol Cell Biol (1991) 1.39
Isoprenoid biosynthesis in bacteria: two different pathways? FEMS Microbiol Lett (1993) 1.39
3-Hydroxy-3-methylglutaryl-coenzyme A reductase from Haloferax volcanii: purification, characterization, and expression in Escherichia coli. J Bacteriol (1996) 1.38
Archaeal genomics: do archaea have a mixed heritage? Curr Biol (1998) 1.38
Cloning, sequencing, and overexpression of mvaA, which encodes Pseudomonas mevalonii 3-hydroxy-3-methylglutaryl coenzyme A reductase. J Bacteriol (1989) 1.31
Identification of the catalytically important histidine of 3-hydroxy-3-methylglutaryl-coenzyme A reductase. J Biol Chem (1992) 1.30
Distribution of the mevalonate and glyceraldehyde phosphate/pyruvate pathways for isoprenoid biosynthesis in unicellular algae and the cyanobacterium Synechocystis PCC 6714. Biochem J (1998) 1.29
A bacterial antibiotic resistance gene with eukaryotic origins. Curr Biol (1998) 1.26
Biochemistry and molecular biology of sterol synthesis in Saccharomyces cerevisiae. Crit Rev Biochem Mol Biol (1999) 1.25
Substrate-induced closure of the flap domain in the ternary complex structures provides insights into the mechanism of catalysis by 3-hydroxy-3-methylglutaryl-CoA reductase. Proc Natl Acad Sci U S A (1999) 1.23
Purification, characterization, and cloning of a eubacterial 3-hydroxy-3-methylglutaryl coenzyme A reductase, a key enzyme involved in biosynthesis of terpenoids. J Bacteriol (1999) 1.21
Identification of the principal catalytically important acidic residue of 3-hydroxy-3-methylglutaryl coenzyme A reductase. J Biol Chem (1990) 1.20
Determination of mevalonate in blood plasma in man and rat. Mevalonate "tolerance" tests in man. J Lipid Res (1979) 1.20
Functional assignment of Erwinia herbicola Eho10 carotenoid genes expressed in Escherichia coli. Mol Gen Genet (1994) 1.19
Distribution of mevalonate and glyceraldehyde 3-phosphate/pyruvate routes for isoprenoid biosynthesis in some gram-negative bacteria and mycobacteria. FEMS Microbiol Lett (1998) 1.17
D5-Phosphomevalonic acid as the intermediate of the enzymatic synthesis of bacterial phytoene. J Biochem (1962) 1.16
Isoprene biosynthesis in Bacillus subtilis via the methylerythritol phosphate pathway. J Nat Prod (2000) 1.04
Lipopolymers, isoprenoids, and the assembly of the gram-positive cell wall. Crit Rev Microbiol (1984) 1.04
3-hydroxy-3-methylglutaryl coenzyme A reductase of Sulfolobus solfataricus: DNA sequence, phylogeny, expression in Escherichia coli of the hmgA gene, and purification and kinetic characterization of the gene product. J Bacteriol (1997) 1.03
Molecular cloning of human phosphomevalonate kinase and identification of a consensus peroxisomal targeting sequence. J Biol Chem (1996) 0.98
Incorporation of radioactive mevalonate into C50 and C55 phenols by Streptococcus mutans. Biochem J (1973) 0.94
Regulatory sequences involved in the promotion and termination of RNA transcription. Annu Rev Genet (1979) 54.83
A system to study promoter and terminator signals recognized by Escherichia coli RNA polymerase. Gene Amplif Anal (1981) 8.21
Characterization by automated DNA sequencing of mutations in the gene (rpoB) encoding the RNA polymerase beta subunit in rifampin-resistant Mycobacterium tuberculosis strains from New York City and Texas. J Clin Microbiol (1994) 6.91
Location of disulphide bridges by diagonal paper electrophoresis. The disulphide bridges of bovine chymotrypsinogen A. Biochem J (1966) 5.98
Identification of critical staphylococcal genes using conditional phenotypes generated by antisense RNA. Science (2001) 5.40
The relationship between function and DNA sequence in an intercistronic regulatory region in phage lambda. Nature (1978) 5.38
Diverse spermatogenic defects in humans caused by Y chromosome deletions encompassing a novel RNA-binding protein gene. Nat Genet (1995) 5.02
Crystal structure of an HIV-binding recombinant fragment of human CD4. Nature (1990) 4.81
The product of ras is a GTPase and the T24 oncogenic mutant is deficient in this activity. Nature (1984) 4.61
Purified lambda regulatory protein cII positively activates promoters for lysogenic development. Nature (1981) 4.60
Termination of transcription in E. coli. Cell (1983) 4.42
Efficient expression of Escherichia coli galactokinase gene in mammalian cells. Proc Natl Acad Sci U S A (1982) 4.25
Ferritin: a cytoprotective antioxidant strategem of endothelium. J Biol Chem (1992) 4.22
Clinical and immunologic criteria for the diagnosis of allergic bronchopulmonary aspergillosis. Ann Intern Med (1977) 4.14
Efficient translation of prokaryotic mRNAs in a eukaryotic cell-free system requires addition of a cap structure. Nature (1979) 4.11
The use of pKc30 and its derivatives for controlled expression of genes. Methods Enzymol (1983) 3.90
Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL. J Biol Chem (1998) 3.88
Microinjection of the oncogene form of the human H-ras (T-24) protein results in rapid proliferation of quiescent cells. Cell (1984) 3.81
Human immunodeficiency virus protease expressed in Escherichia coli exhibits autoprocessing and specific maturation of the gag precursor. Proc Natl Acad Sci U S A (1987) 3.72
Termination of transcription in bacteriophage lambda. Heterogeneous, 3'-terminal oligo-adenylate additions and the effects of rho factor. J Biol Chem (1975) 3.71
Two restriction and modification systems in Staphylococcus aureus NCTC8325. J Gen Microbiol (1976) 3.64
Human actinomycosis. A study of 181 subjects. Hum Pathol (1973) 3.63
Surveillance and prevention of residential-fire injuries. N Engl J Med (1996) 3.60
Translational coupling at an intercistronic boundary of the Escherichia coli galactose operon. Cell (1982) 3.56
Tissue-specific and differentiation-specific expression of a human K14 keratin gene in transgenic mice. Proc Natl Acad Sci U S A (1989) 3.55
A functional genomic analysis of type 3 Streptococcus pneumoniae virulence. Mol Microbiol (2001) 3.53
A genomic analysis of two-component signal transduction in Streptococcus pneumoniae. Mol Microbiol (2000) 3.50
Incompatibility and molecular relationships between small Staphylococcal plasmids carrying the same resistance marker. Plasmid (1978) 3.30
Highly reiterated sequences of SIMIANSIMIANSIMIANSIMIANSIMIAN. Science (1978) 3.29
Expression and characterization of the human c-myc DNA-binding protein. Mol Cell Biol (1985) 3.24
Constitutive function of a positively regulated promoter reveals new sequences essential for activity. J Biol Chem (1987) 3.23
Evolutionary similarities between pancreatic proteolytic enzymes. Nature (1965) 3.18
Regrowth of Pseudomonas aeruginosa and other bacteria after the bactericidal action of carbenicillin and other beta-lactam antibiotics. J Infect Dis (1981) 3.00
Role of adherence in growth of Acinetobacter calcoaceticus RAG-1 on hexadecane. J Bacteriol (1981) 2.96
gridlock, an HLH gene required for assembly of the aorta in zebrafish. Science (2000) 2.90
Control of pT181 replication I. The pT181 copy control function acts by inhibiting the synthesis of a replication protein. EMBO J (1984) 2.87
Nucleotide sequence homology at the 3' termini of RNA from vesicular stomatitis virus and its defective interfering particles. Proc Natl Acad Sci U S A (1978) 2.82
Sequence of Cro gene of bacteriophage lambda. Nature (1977) 2.78
Copper metallothionein of yeast, structure of the gene, and regulation of expression. Proc Natl Acad Sci U S A (1984) 2.74
Adherence of Acinetobacter calcoaceticus RAG-1 to human epithelial cells and to hexadecane. Infect Immun (1981) 2.74
Bacterial adherence to polystyrene: a replica method of screening for bacterial hydrophobicity. Appl Environ Microbiol (1981) 2.73
E1A 13S and 12S mRNA products made in Escherichia coli both function as nucleus-localized transcription activators but do not directly bind DNA. Mol Cell Biol (1985) 2.68
Genomic sequence of hyperthermophile, Pyrococcus furiosus: implications for physiology and enzymology. Methods Enzymol (2001) 2.67
Systematic identification of selective essential genes in Helicobacter pylori by genome prioritization and allelic replacement mutagenesis. J Bacteriol (2001) 2.63
Endocytosis in Chang liver cells. Quantitation by sucrose- 3 H uptake and inhibition by cytochalasin B. J Cell Biol (1971) 2.63
A rho-dependent termination site in the gene coding for tyrosine tRNA su3 of Escherichia coli. Nature (1978) 2.58
Affecting gene expression by altering the length and sequence of the 5' leader. Proc Natl Acad Sci U S A (1984) 2.58
Nucleotide sequence of the operator-promoter region of the galactose operon of Escherichia coli. Proc Natl Acad Sci U S A (1977) 2.57
Microinjected c-myc as a competence factor. Science (1985) 2.56
Evolution of two-component signal transduction. Mol Biol Evol (2000) 2.55
Envelope glycoproteins from biologically diverse isolates of immunodeficiency viruses have widely different affinities for CD4. Proc Natl Acad Sci U S A (1991) 2.54
Structural origins of mammalian albumin. Fed Proc (1976) 2.49
ESSAYS ON SCIENCE AND SOCIETY: Privatizing the University--the New Tragedy of the Commons. Science (2000) 2.44
Adenovirus E1a gene product expressed at high levels in Escherichia coli is functional. Science (1984) 2.38
Structure and function of the cy control region of bacteriophage lambda. J Mol Biol (1980) 2.37
A promoter of pBR322 activated by cAMP receptor protein. Nucleic Acids Res (1981) 2.37
Differential diagnostic patterns of dysarthria. J Speech Hear Res (1969) 2.34
Pentapeptide nuclear localization signal in adenovirus E1a. Mol Cell Biol (1987) 2.30
pT181 plasmid replication is regulated by a countertranscript-driven transcriptional attenuator. Cell (1989) 2.28
The influence of age, diagnosis, and gender on proper use of metered-dose inhalers. Am J Respir Crit Care Med (1994) 2.23
Promoter for the establishment of repressor synthesis in bacteriophage lambda. Proc Natl Acad Sci U S A (1980) 2.23
Efficient expression of influenza virus NS1 nonstructural proteins in Escherichia coli. Proc Natl Acad Sci U S A (1983) 2.19
Removal of a terminator structure by RNA processing regulates int gene expression. J Mol Biol (1984) 2.13
Bacteriophage lambda protein cII binds promoters on the opposite face of the DNA helix from RNA polymerase. Nature (1983) 2.13
Nucleotide sequences of the 5' and 3' termini of bacteriophage T7 early messenger RNAs synthesized in vivo: evidence for sequence specificity in RNA processing. J Mol Biol (1974) 2.10
Sites of phosphorylation on pyruvate dehydrogenase from bovine kidney and heart. Biochemistry (1978) 2.10
Interaction between FKBP12-rapamycin and TOR involves a conserved serine residue. J Biol Chem (1994) 2.04
The effects of a 5-lipoxygenase inhibitor on asthma induced by cold, dry air. N Engl J Med (1990) 2.03
Clusters of deviant speech dimensions in the dysarthrias. J Speech Hear Res (1969) 2.00
The expression in yeast of the Escherichia coli galK gene on CYC1::galK fusion plasmids. Gene (1983) 1.98
FosB mutant mice: loss of chronic cocaine induction of Fos-related proteins and heightened sensitivity to cocaine's psychomotor and rewarding effects. Proc Natl Acad Sci U S A (1997) 1.98
Characterization of the functional gene and several processed pseudogenes in the human triosephosphate isomerase gene family. Mol Cell Biol (1985) 1.97
Characterization of short tandem repeats from thirty-one human telomeres. Genome Res (1997) 1.96
Functions of purified E1A protein microinjected into mammalian cells. Proc Natl Acad Sci U S A (1984) 1.92
Synthesis of the complete trans-activation gene product of human T-lymphotropic virus type III in Escherichia coli: demonstration of immunogenicity in vivo and expression in vitro. Proc Natl Acad Sci U S A (1986) 1.90
Psychosexual trauma of an abnormal cervical smear. Br J Obstet Gynaecol (1988) 1.90
Coding sequence for the pT181 repC product: a plasmid-coded protein uniquely required for replication. Proc Natl Acad Sci U S A (1982) 1.89
Regulated antisense RNA eliminates alpha-toxin virulence in Staphylococcus aureus infection. J Bacteriol (1999) 1.88
Differential translation efficiency explains discoordinate expression of the galactose operon. Cell (1981) 1.87
Microarray-based identification of htrA, a Streptococcus pneumoniae gene that is regulated by the CiaRH two-component system and contributes to nasopharyngeal colonization. Infect Immun (2002) 1.87
Dimerization and membrane anchors in extracellular targeting of vancomycin group antibiotics. Antimicrob Agents Chemother (1995) 1.86
Phylogenetic analyses do not support horizontal gene transfers from bacteria to vertebrates. Nature (2001) 1.85
Activation of human immunodeficiency virus type 1 by DNA damage in human cells. Nature (1988) 1.85
The 289-amino acid E1A protein of adenovirus binds zinc in a region that is important for trans-activation. Proc Natl Acad Sci U S A (1988) 1.84
Characterization of reproductive hormonal dynamics in the perimenopause. J Clin Endocrinol Metab (1996) 1.80
Two promoters, one inducible and one constitutive, control transcription of the Streptomyces lividans galactose operon. Proc Natl Acad Sci U S A (1987) 1.79
Purification and characterization of human H-ras proteins expressed in Escherichia coli. Mol Cell Biol (1985) 1.77
Impaired nuclear transport of a human variant tRNAiMet. Nature (1982) 1.75
Inhibition of bacterial adherence to hydrocarbons and epithelial cells by emulsan. Infect Immun (1983) 1.71
Trimellitic anhydride-induced airway syndromes: clinical and immunologic studies. J Allergy Clin Immunol (1977) 1.71
Microbicides--evaluating multiple formulations of C31G. Contraception (2002) 1.67
Length heteroplasmy of sturgeon mitochondrial DNA: an illegitimate elongation model. Genetics (1990) 1.65
Studying promoters and terminators by gene fusion. Science (1983) 1.64
Serum IgE and IgG antibody activity against Aspergillus fumigatus as a diagnostic aid in allergic bronchopulmonary aspergillosis. Am Rev Respir Dis (1978) 1.62